Tianjin Lisheng Pharmaceutical Co.,Ltd. (SHE:002393)
China · Delayed Price · Currency is CNY 14.29
+0.30 (2.14%)
Jul 30, 2026, 9:25 AM CST
SHE:002393 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 1,354 | 1,392 | 1,336 | 1,153 | 1,147 | 1,092 |
Revenue Growth | 0.99% | 4.18% | 15.88% | 0.56% | 5.00% | -4.29% |
Gross Profit Gross Profit Growth | 716.32 | 747.08 | 712.11 | 665.06 | 636.08 | 618 |
Operating Income Operating Income Growth | 108.9 | 93.46 | 69.41 | 118.6 | 61.05 | 28.66 |
Net Income Net Income Growth | 412.89 | 416.28 | 184.53 | 361.83 | 93.61 | 122.11 |
Earnings Per Share EPS Growth | 1.34 | 1.35 | 0.60 | 1.17 | 0.30 | 0.40 |
EPS Growth | 130.17% | 125.00% | -48.57% | 284.29% | -23.87% | 1238.26% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Northern China Northern China Growth | 579.59 | 497.76 | 552.77 | 496.66 | 446.15 |
Northeast China Northeast China Growth | 53.88 | 61.17 | 20.17 | 25.07 | 25.57 |
East China East China Growth | 322.92 | 307.6 | 224.86 | 270.81 | 241.41 |
South Central China South Central China Growth | 228.87 | 280.25 | 202.74 | 160.64 | 187.33 |
Southwest China Southwest China Growth | 119.22 | 113.43 | 90.83 | 122.7 | 126.51 |
North-West China North-West China Growth | 84.85 | 73.55 | 58.91 | 66.95 | 60.95 |
Export Export Growth | 2.68 | 2.38 | 2.75 | 3.75 | 4.02 |
Total Total Growth | 1,392 | 1,336 | 1,153 | 1,147 | 1,092 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 2,482 | 2,558 | 2,369 | 2,220 | 1,994 | 1,652 |
Total Debt Total Debt Growth | 43.93 | 45.49 | 51.01 | 33.42 | 45.08 | 34.74 |
Net Cash (Debt) Net Cash Growth | 2,438 | 2,513 | 2,318 | 2,187 | 1,949 | 1,617 |
Net Cash Growth | 17.28% | 8.39% | 6.01% | 12.23% | 20.49% | 4.86% |
Net Cash Per Share Net Cash Per Share Growth | 7.94 | 8.15 | 7.54 | 7.05 | 6.32 | 5.28 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 249.46 | 247.5 | 88.26 | 200.01 | 331.38 | 196.34 |
Capital Expenditures CapEx Growth | -34.76 | -37.46 | -53.75 | -61.72 | -40.91 | -88.24 |
Free Cash Flow Free Cash Flow Growth | 214.7 | 210.04 | 34.51 | 138.29 | 290.47 | 108.1 |
Free Cash Flow Growth | - | 508.58% | -75.04% | -52.39% | 168.71% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 52.89% | 53.67% | 53.30% | 57.68% | 55.48% | 56.60% |
Operating Margin | 8.04% | 6.71% | 5.20% | 10.29% | 5.32% | 2.62% |
Pretax Margin | 33.26% | 32.73% | 16.16% | 36.44% | 10.32% | 12.56% |
Profit Margin | 30.48% | 29.90% | 13.81% | 31.38% | 8.16% | 11.18% |
FCF Margin | 15.85% | 15.09% | 2.58% | 11.99% | 25.33% | 9.90% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 1.000 | 0.750 | 0.292 | 0.357 | 0.179 | 0.179 |
Dividend Per Share Growth | 191.43% | 157.11% | -18.31% | 99.94% | 0% | 200.17% |
Dividend Yield | 7.15% | 4.32% | 2.11% | 2.51% | 1.56% | 1.56% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 10.63 | 13.36 | 24.45 | 13.29 | 41.85 | 32.29 |
Forward PE | - | 18.18 | 18.18 | 18.18 | 18.18 | 18.18 |
P/FCF Ratio | 20.51 | 26.48 | 130.72 | 34.78 | 13.49 | 36.48 |
PS Ratio | 3.25 | 4.00 | 3.38 | 4.17 | 3.42 | 3.61 |